ADUS241220P110000
- 0.00
- 0.000.00%
Addus HomeCare Newsroom
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $136
RBC Capital Reaffirms Their Buy Rating on Addus Homecare (ADUS)
Addus HomeCare's (NASDAQ:ADUS) One-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Addus HomeCare to Participate in Stephens Annual Investment Conference
Addus HomeCare's (NASDAQ:ADUS) Promising Earnings May Rest On Soft Foundations
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $141
Earnings Call: Addus HomeCare Reports Solid Q3 Growth, Eyes Acquisitions
TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Raises Target Price to $141
Addus HomeCare Price Target Raised to $145.00/Share From $143.00 by Stephens & Co.
Hospital Stocks Could See Negative Impact Under Trump
Addus HomeCare Is Maintained at Outperform by RBC Capital
RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Cuts Target Price to $136
Oppenheimer Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $145
A Quick Look at Today's Ratings for Addus HomeCare(ADUS.US), With a Forecast Between $83 to $145
Addus HomeCare Third Quarter 2024 Earnings: EPS Misses Expectations
Express News | Addus Homecare Corp : RBC Cuts Target Price to $136 From $141
Addus HomeCare | 10-Q: Q3 2024 Earnings Report
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript Summary
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript
Barclays Maintains Addus HomeCare(ADUS.US) With Sell Rating, Maintains Target Price $83